Is NAGE diluting shareholders?

Read three numbers together: shares outstanding over time (79.1M as of 2026-07-30), warrants that can convert into new shares, and how much cash runway remains. A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

Niagen Bioscience, Inc. (NAGE)

CIK 1386570 · all EDGAR filings →

Overall dilution risk

HIGHworst of 3 computed signals (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

not every sub-rating was computable; treat as a floor

Offering ability

HIGH$125M registered

= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)

registered capacity, not remaining: amounts already taken down are not subtracted yet

Overhead supply

NOT COMPUTEDno warrant count tagged in XBRL

= warrant shares outstanding divided by current shares outstanding

absence of a tag is not proof of absence of warrants

Historical dilution

LOW+5% O/S in 3y

= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative

a reverse-split-sized cliff is in this window; read the chart

Cash need

LOWoperating cash flow positive

= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Latest: 79.1M shares as of Jul 30, 2026 (10-Q). Share count fell from 109.5M to 36.6M between Mar 16, 2016 and May 11, 2016, a pattern consistent with a reverse split (roughly 1-for-3); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Reported exercise price: $4.8 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $4.4M as of Mar 30, 2013.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 4, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $125.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Jun 29, 2026$125.0M registeredfiling →

Last 12 months: 1 executed · 1 registered.

EXECUTEDJul 10, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

EFFECTIVEJul 9, 2026SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDJun 29, 2026S-3 registration — capacity to sell shares, not a sale yetS-3 →

UPDATENov 21, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →

EXECUTEDJul 6, 2023Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

EFFECTIVEJul 5, 2023SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDJun 22, 2023S-3 registration — capacity to sell shares, not a sale yetS-3 →

UPDATENov 17, 2022Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVENov 16, 2022SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDNov 3, 2022S-3 registration — capacity to sell shares, not a sale yetS-3 →

EXECUTEDOct 11, 2022Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →

UPDATEApr 22, 2021Prospectus update — often a resale registration, not necessarily new capital424B3 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full NAGE workspace